Clark; Robin D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Clark; Robin D..The latest application filed is for "fused ring azadecalin glucocorticoid receptor modulators".

Company Profile

0.23.8

Clark; Robin D. - Lawai HI
Clark; Robin D. - Kalaheo HI
Clark; Robin D. - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused Ring Azadecalin Glucocorticoid Receptor Modulators App 20140179671 - Clark; Robin D. ; et al.	2014-06-26
Fused ring azadecalin glucocorticoid receptor modulators Grant 8,557,839 - Clark , et al. October 15, 2	2013-10-15
Azadecalin glucocorticoid receptor modulators Grant 8,324,203 - Clark , et al. December 4, 2	2012-12-04
Fused Ring Azadecalin Glucocorticoid Receptor Modulators App 20120225856 - Clark; Robin D. ; et al.	2012-09-06
Modified pyrimidine glucocorticoid receptor modulators Grant 8,173,664 - Clark , et al. May 8, 2	2012-05-08
Fused Ring Azadecalin Glucocorticoid Receptor Modulators App 20110166110 - Clark; Robin D. ; et al.	2011-07-07
Fused ring azadecalin glucocorticoid receptor modulators Grant 7,928,237 - Clark , et al. April 19, 2	2011-04-19
Azadecalin Glucocorticoid Receptor Modulators App 20100120759 - CLARK; Robin D. ; et al.	2010-05-13
Azadecalin Glucocorticoid receptor modulators Grant 7,678,813 - Clark , et al. March 16, 2	2010-03-16
Modified Pyrimidine Glucocorticoid Receptor Modulators App 20090275600 - Clark; Robin D. ; et al.	2009-11-05
Modified pyrimidine glucocorticoid receptor modulators Grant 7,576,076 - Clark , et al. August 18, 2	2009-08-18
Fused Ring Azadecalin Glucocorticoid Receptor Modulators App 20070281928 - Clark; Robin D. ; et al.	2007-12-06
Azadecalin Glucocorticoid Receptor Modulators App 20070203179 - Clark; Robin D. ; et al.	2007-08-30
Modified pyrimidine glucocorticoid receptor modulators App 20060025405 - Clark; Robin D. ; et al.	2006-02-02
Isoindolinyl derivatives Grant 5,726,197 - Clark , et al. March 10, 1	1998-03-10
Isoquinolinone and dihydroisoquinolinone 5-HT.sub.3 receptor antagonists Grant 5,491,148 - Berger , et al. February 13, 1	1996-02-13
Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid Grant 5,412,102 - Clark , et al. May 2, 1	1995-05-02
Substituted indole derivatives Grant 5,380,739 - Clark , et al. * January 10, 1	1995-01-10
Substituted indole antagonists derivatives which are angiotensin II Grant 5,212,195 - Clark , et al. May 18, 1	1993-05-18
Tricyclic 5-HT.sub.3 receptor antagonists Grant 5,202,333 - Berger , et al. April 13, 1	1993-04-13
Serotonergic alpha-oxoacetamides Grant 5,192,770 - Clark , et al. March 9, 1	1993-03-09
Tricyclic 5-HT.sub.3 receptor antagonists Grant 5,189,041 - Berger , et al. February 23, 1	1993-02-23
1,9-alkano-bridged-2,3,4,5-tetrahydro-1H-3-benzazepines Grant 4,957,914 - Clark , et al. September 18, 1	1990-09-18
Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry Grant 4,567,264 - Kluge , et al. January 28, 1	1986-01-28
Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and .beta.-blockade Grant 4,558,129 - Kluge , et al. December 10, 1	1985-12-10
Laidlomycin phenylcarbamate Grant 4,542,027 - Clark September 17, 1	1985-09-17
Acylated laidlomycin derivatives Grant 4,431,665 - Kluge , et al. February 14, 1	1984-02-14
9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones Grant 4,353,900 - Clark October 12, 1	1982-10-12
9-(1,4-Benzodioxan-2-ylalkyl and hydroxyalkyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-ones Grant 4,353,901 - Clark October 12, 1	1982-10-12
9-[2-(3-Indolyl)ethyl]-1oxa-4,9-diazaspiro[5.5]undecan-3-ones Grant 4,332,804 - Clark June 1, 1	1982-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.